Nearly 97% of residents from the nine programs included in this latest research reported a lack of sufficient exposure to AI during their training.

The U.S. Food and Drug Administration granted Philips 510(k) clearance for its AI-powered MRI platform tailored to the treatment of head and neck cancers. 

Ed Nicol, MD, president-elect of the Society of Cardiovascular Computed Tomography, provided us with an exclusive look at how AI is expected to change cardiac imaging.

ACR TI-RADS has previously been shown to lack sensitivity for distinguishing between benign and malignant thyroid lesions in pediatric patients.

Radiomics methodologies could change how care plans are managed for patients with breast cancer by identifying those most likely to benefit from specific treatments.

Connie Lehman, MD, chief of breast imaging, co-director of the Avon Comprehensive Breast Evaluation Center at Massachusetts General Hospital, discusses how artificial intelligence (AI) is being implemented in breast imaging.

The solutions, Plaque Analysis and RoadMap Analysis, both use coronary CT angiography to provide clinicians with a noninvasive look at patients who present with coronary artery disease and face a heightened myocardial infarction risk.

“This study implies that future clinical workflows may see AI be used in an adjunct capacity to improve interpretations of CT scans by helping call radiologists' attention to findings that may be overlooked.”